Advanced Medical Isotope Shares Outstanding 2013-2024 | RDGL
Advanced Medical Isotope shares outstanding from 2013 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Advanced Medical Isotope Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 410 |
| 2023 | 369 |
| 2022 | 351 |
| 2021 | 326 |
| 2020 | 223 |
| 2019 | 175 |
| 2018 | 56 |
| 2017 | 6 |
| 2016 | 3 |
| 2015 | 2 |
| 2014 | 0 |
| 2013 | 0 |
| 2012 | 0 |
| Advanced Medical Isotope Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | 410 |
| 2024-09-30 | 419 |
| 2024-06-30 | 403 |
| 2024-03-31 | 389 |
| 2023-12-31 | 369 |
| 2023-09-30 | 371 |
| 2023-06-30 | 368 |
| 2023-03-31 | 363 |
| 2022-12-31 | 351 |
| 2022-09-30 | 344 |
| 2022-06-30 | 344 |
| 2022-03-31 | 344 |
| 2021-12-31 | 326 |
| 2021-09-30 | 336 |
| 2021-06-30 | 328 |
| 2021-03-31 | 301 |
| 2020-12-31 | 223 |
| 2020-09-30 | 234 |
| 2020-06-30 | 173 |
| 2020-03-31 | 189 |
| 2019-12-31 | 175 |
| 2019-09-30 | 178 |
| 2019-06-30 | 173 |
| 2019-03-31 | 166 |
| 2018-12-31 | 56 |
| 2018-09-30 | 48 |
| 2018-06-30 | 11 |
| 2018-03-31 | 8 |
| 2017-12-31 | 6 |
| 2017-09-30 | 7 |
| 2017-06-30 | 6 |
| 2017-03-31 | 5 |
| 2016-12-31 | 3 |
| 2016-09-30 | 3 |
| 2016-06-30 | 2 |
| 2016-03-31 | 2 |
| 2015-12-31 | 2 |
| 2015-09-30 | 2 |
| 2015-06-30 | 2 |
| 2015-03-31 | 2 |
| 2014-12-31 | 0 |
| 2014-09-30 | 0 |
| 2014-06-30 | 0 |
| 2014-03-31 | 0 |
| 2013-12-31 | 0 |
| 2013-09-30 | 0 |
| 2013-06-30 | 0 |
| 2013-03-31 | 0 |
| 2012-12-31 | 0 |
| 2012-09-30 | 0 |
| 2012-06-30 | 0 |
| 2012-03-31 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | FIN-SBIC&COMMRL | $0.068B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||